Biochemical markers of type 1 diabetes: clinical use

REFERENCES

• Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati 0, Raghu PK et al. Insulin antibodies in insulin-dependent diabetics before insulin treat-ment. Science 1983; 222:1337–9.
   Google Scholar
• Karjalainen J, Knip M, Mustonen A, Ilonen J, Akerblom HK. Relationen between insulin anti-body and complement-fixing islet cell antibody at clinical diagnosis of IDDM. Diabetes 1986; 35: 620–2.
   Google Scholar
• Vardi P, Ziegler AG, Mathews JH, Dib S, Keller RJ, Ricker AT et al. Concentration of insulin autoantibodies at onset of type 1 diabetes: in-verse log-linear correlation with age. Diabetes Care 1988; 111:736–9.
   Google Scholar
• Harrison LC, de Aizpurua H, Loudovaris T, Campbell IL, Cebon JS, Tait BD et al. Reactiv-ity to human islets and fetal pig proislets by pe-ripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes. Diabetes 1991;40: 1128.33.
   Google Scholar
• Miller GG, Pollack MS, Nell LJ, Thomas JW. Insulin-specific human T cells. Epitope speci-ficity, major histocompatibility complex restric-tion, and alloreactivity to a diabetes-associated haplotype. J Immunol 1987; 139:3622–9.
   Google Scholar
• Sarugeri E, Dozio N, Belloni C, Meschji F, Pastore MR, Bonifacio E. Autoimmune re-sponses to the p cell autoantigen, insulin, and the INS VNTR-IDDM2 locus. Clin Exp Immu-nol 1998; 114:370–6.
   PubMedGoogle Scholar
• French MB, Allison J, Cram DS, Thomas HE, M. D-C, Silva A et al. Transgenic expression of mouse proinsulin II prevents diabetes in non obese diabetic mice. Diabetes 1997;46:34–9.
   Google Scholar
• Bohmer K, Keilacker H, Kuglin B, Hubinger A, Bertrams J, Gries FA et al. Proinsulin autoanti-bodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insu-lin autoantibodies. Diabetologia 1991;34:830–4.
   PubMedGoogle Scholar
• Maron R, Elias D, de Jongh BM, Bruining GJ, van Rood JJ, Shecter Y et al. Autoantibodies to the insulin receptor in juvenile onset insulin-dependent diabetes. Nature 1983;303:817–818.
   PubMedGoogle Scholar
• Baekkeskov S, HOiriis Nielsen J,. Marner B, Bilde T, Ludvigsson J, Lernmark A. Autoanti-bodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982;298:167–9.
   Google Scholar
• Baekkeskov S, Warnock G, Christie M, Rajotte R.V, Larsen PM, Fey S. Revelation of specific-ity of 64K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis. Diabe-tes 1989;38:1133–41.
   PubMed Web of Science ®Google Scholar
• Atkinson MA, Mclaren NK, Scharp DW, Lacy PE, Riley WJ, 64 000 Mr autoantibodies as pre-dictors of insulin-dependent diabetes. Lancet 1990;335 :1357–60.
   PubMed Web of Science ®Google Scholar
• Baekkeskov S, Aanstoot H-J, Christgau S, Reetz A, Solimena M, Cascalho M et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA- synthesizing enzyme glutamicaciddecarboxylase.Nature1990;347:151–6.
   PubMed Web of Science ®Google Scholar
• Bu DF, Erlander MG, Hitz BC, Tillakarante NJK, Kaufman DL, Wagner-McPherson CB et al. Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene. Proc Natl Adac Sci 1992;89:2115–9.
   PubMed Web of Science ®Google Scholar
• Michelsen BK, Petersen JS, Boel E, MOldrup A, Dyrberg T, Dragsbaek Madsen 0. Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus. Proc Natl Acad Sci 1991;88:8754–8.
   Google Scholar
• Lohmann T, Leslie RDG, Hawa M, Geysen M, Rodda S, Londei M. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in in-sulin-dependent diabetes mellitus. Lancet 1994;343:1607–8.
   PubMed Web of Science ®Google Scholar
• Harrison LC, Honeyman MC, De Aizpurua HJ, Schmidli RS, Colman PG, Tait BD et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 1993;341:1365–9.
   PubMed Web of Science ®Google Scholar
• Atkinson MA, Kaufman DL, Campbell L, Gibbs KA, Shah SC, Bu D-F et al. Response of periph-eral-blood mononuclear cells to glutamate de-carboxylase in insulin-dependent diabetes. Lan-cet 1992,339:458–9.
   PubMed Web of Science ®Google Scholar
• Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S.P., Robinson P et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993;366:69–72.
   Google Scholar
• Worsaae A, Hejnaes K, Moody A, Ludvigsson J, Pociot F, Lorenzen T et al. T cell proliferative responses to glutamic acid decarboxylase-65 in IDDM are negatively associated with HLA DR3/4. Autoimmunity 1995;22:183–9.
   PubMed Web of Science ®Google Scholar
• Lan MS, Lu J, Goto Y, Notkins AL. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA and Cell Biology 1994;13:505–14.
   PubMed Web of Science ®Google Scholar
• Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A et al. IA-2 auto-antibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetolo-gia 1997;40:95–9.
   PubMedGoogle Scholar
• Verge CF, Gianani R, Kawasaki E, Yu L, Pie-tropaolo M, Jackson RA et al. Prediction of type 1 diabetes in first-degree relatives using a com-bination of insulin, GAD and ICA512bdc/IA-2 autoantibodies. Diabetes 1996;45:926–33.
   PubMed Web of Science ®Google Scholar
• Verge CF, Gianani R, Kawasaki E, Yu L, Pie-tropaolo M, Jackson RA et al. Prediction of type 1 diabetes in first-degree relatives using a com-bination of insulin, GAD and ICA512bdc/IA-2 autoantibodies. Diabetes 1996;45:926–33.
   PubMed Web of Science ®Google Scholar
• Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A et al. IA-2 auto-antibodies complement GAD65-autoantibodies in new-onset 1DDM patients and help predict impending diabetes in their siblings. Diabetolo-gia 1997;40:95–9.
   PubMedGoogle Scholar
• Bonifacio E, Bingley PJ, Dean BM et al. Quanti-fication of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990; 335: 147–9.
   PubMed Web of Science ®Google Scholar
• Karjalainen J. Islet cell antibodies as predictive markers for IDDM in children with high back-ground incidence of disease. Disease 1990;39:1144–50.
   Google Scholar
• Bruining GJ, Molenaar JL, Grobbee DE et al. Ten-year follow-up study of islet cell antibodies and childhood diabetes mellitus. Lancet 1989; i: 1100–3.
   Google Scholar
• Bingley PJ, Bonifacio E, Shattock M et al. Can islet cell antibodies predict IDDM in the general population? Diabetes Care 1993;16:45–50.
   PubMed Web of Science ®Google Scholar
• Pozzilli P, Visalli N, Buzzetti R, Cavallo MG, Marietti G, Leslie RDG. Metabolic and immune parameters at clinical onset of insulin dependent diabetes: a population based study. Metabolism 1998; 47:1205–10.
   PubMedGoogle Scholar
• Hawa MI, Rowe RE, Lan MS, Notkins AL, Pozzilli P, Christie MR, Leslie RDG. Antibodies to tyrosine phophatase-like molecule in type 1 diabetes: a new predictive marker of the disease. Diabetes 1997 ;46: 1270–5.
   Google Scholar